Navigation Links
Regado Biosciences, Inc. to Present at the Oppenheimer 23rd Annual Healthcare Conference in New York, NY
Date:12/5/2012

BASKING RIDGE, N.J., Dec. 5, 2012 /PRNewswire/ -- Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced that David J. Mazzo, PhD, President and CEO, will be presenting at the Oppenheimer 23rd Annual Healthcare Conference at 11:10 a.m. ET on Wednesday, December 12, 2012 in the Louis XVI Room at the Waldorf Astoria in New York City.

The presentation will include an overview of the Company's pipeline with emphasis on the lead development program, the innovative anticoagulant system REG1, including a summary of the groundbreaking results of the REG1 phase 2b trial (RADAR).  Additionally, a summary of the positive results of the FDA end-of-phase 2 meeting and a description of the resulting phase 3 development program and timeline, minimized for cost and maximized for probability of success, will be provided.

ABOUT REGADO BIOSCIENCES
Regado Biosciences, Inc. is a private biopharmaceutical company pioneering a new therapeutic technology with the creation and development of proprietary controllable aptamer drug systems.  Each system comprises a nuclease-stabilized RNA aptamer, the therapeutic effect of which can be reversed partially or completely in real time by its specific and complementary oligonucleotide active control agent. This technology is being applied to injectable antithrombotics (including anticoagulants and antiplatelet agents) in the acute and sub-acute care cardiovascular setting, a multi-billion dollar world-wide market in need of drugs with improved safety profiles and a greater degree of therapeutic control.  The products in Regado's pipeline are designed to act as optimized antithrombotics, uniquely and concomitantly minimizing the risk of ischemia and bleeding, and, by allowing patient specific tuning of the desired therapeutic effect, provide a safe and unique approach to personalized medicine.

'/>"/>

SOURCE Regado Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Regado Biosciences, Inc. to Present at the UBS Global Life Sciences Conference 2012 in New York, NY
2. Regado Biosciences, Inc. to Present at the Canaccord Genuity 32nd Annual Growth Conference in Boston, MA
3. Regado Biosciences, Inc. to Present at the 2012 Wedbush PacGrow Life Sciences Conference in New York, NY
4. Pressure BioSciences, Inc. to Discuss Third Quarter 2012 Financial Results and Provide Business Update
5. Pressure BioSciences, Inc. Reports 70% Revenue Growth for Second Consecutive Quarter
6. Pressure BioSciences, Inc. to Discuss Second Quarter 2012 Financial Results and Provide Business Update
7. Founded by Enlight Biosciences, KNODE partners with AstraZeneca and Other Partners
8. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
9. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
10. Optimer Pharmaceuticals to Present at 23rd Annual Oppenheimer Healthcare Conference
11. PAREXEL International To Present At Oppenheimer Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/18/2014)...  In a policy paper released ... largest lesbian, gay, bisexual and transgender (LGBT) civil ... for Pre-Exposure Prophylaxis (PrEP). PrEP is any medical ... spread of a disease or infection prior to ... drug combination currently approved for PrEP, which protects ...
(Date:10/17/2014)...  Amgen (NASDAQ: AMGN ) today announced ... president of Gladstone Institutes and Gladstone,s Robert W. and ... are pleased to welcome Dr. Sandy Williams ... , chairman and chief executive officer of Amgen. "Dr. ... his direct experience in our industry will both be ...
(Date:10/17/2014)... 2014 According to ... Technique (Optical Coherence Tomography, Hyperspectral Imaging, Photoacoustic ... Neurology, Oncology, Cardiology) - Global Forecasts to ... Optical Imaging market over the forecast period ... $917.1 million in 2014 and is expected ...
Breaking Medicine Technology:HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 2HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 3Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 2Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 3Optical Imaging Market Worth $1,669.2 Million by 2019 2Optical Imaging Market Worth $1,669.2 Million by 2019 3Optical Imaging Market Worth $1,669.2 Million by 2019 4
(Date:10/20/2014)... October 20, 2014 ASCNYC (ascnyc.org) ... that helps New Yorkers living with HIV/AIDS and ... health, housing, recovery and self-sufficiency. Each year, ASCNYC ... local community through their tireless efforts. , ... Shapses , has been selected as this year’s ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Zereana Jess-Huff, a ... Mrs. Maryland 2014 on a platform to think outside the ... and uses her position to raise awareness about women’s other ... for breast cancer. You say the color pink and everybody ... know for a fact that it has not been won ...
(Date:10/20/2014)... CA (PRWEB) October 20, 2014 AttorneyOne.com, a ... the latest information from the FDA on Sit and ... October 10 not to purchase or use Sit and Slim ... and Slim II is promoted as weight loss product on ... removed from the market in 2010 for safety reasons, can ...
(Date:10/20/2014)... October 20, 2014 Based on ... the only imaging assays capable of determining DNA ... test.  With these three dimensions of high-resolution data, ... detect the widest range of disease-causing genetic rearrangements, ... by other genomic tools, including today’s advanced sequencing ...
(Date:10/20/2014)... DALLAS (PRWEB) October 20, 2014 It’s hard ... for many orphans and vulnerable children around the world, it’s ... by some people, many children are forced to walk barefoot ... for their families or play with their friends. , ... partnering with Air1 Radio in October to encourage ...
Breaking Medicine News(10 mins):Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 2Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 3Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3Health News:FDA Advises Not to Use Sit and Slim II: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:KromaTiD Launches Genome Screening and Discovery Services 2Health News:KromaTiD Launches Genome Screening and Discovery Services 3Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 3
... A new report released Wednesday,February 11, 2009 by ... physical activity, Special Olympics athletes are more physically active,than ... , U.S. Vice President Joe ... Winter Games in Boise, Idaho on Thursday, February 12, ...
... Virtua Health has responded to the public regarding legal action ... Court judge ordered Virtua to stop its Top Doc advertising ... advertising statements are fraudulent. Cooper also sent an e-mail to ... "Virtua has always had the highest ethical standards and ...
... , ... Eagan, MN (Vocus) February 11, 2009 -- Employees of DeCare ... Northeastern Minnesota. A company cookbook was created and recipes were gathered ... than 200 cookbooks were sold. , , , , ,"After years ...
... Feb. 11 Cogdell Spencer Inc. (NYSE:, CSA ... of the Northwest,Region for the Company,s wholly owned subsidiary, ... Based in the Company,s Seattle office, Mr. Aigner ... be responsible for all,design-build and development projects in the ...
... with salivary gland , , WEDNESDAY, Feb. 11 (HealthDay News) -- A ... who blew his tuba so hard that he sent air into ... the condition after the boy developed swelling and pain around his ... Deepa Mukundan, who wrote about the case in the Feb. 12 ...
... ("Transition" or the "Company") (TSX: TTH; NASDAQ: ... disease indications with large markets, today announced its financial ... Selected Highlights, -------------------, ... and up to the date of this press,release, the ...
Cached Medicine News:Health News:Special Olympics Issues Report on the Impact of Special Olympics Healthy Athletes Initiative to show Need for Reauthorization of the Special Olympics Sport and Empowerment Act of 2004 2Health News:Special Olympics Issues Report on the Impact of Special Olympics Healthy Athletes Initiative to show Need for Reauthorization of the Special Olympics Sport and Empowerment Act of 2004 3Health News:Virtua Health Responds to Court Order 2Health News:Company Cookbook Proceeds to Benefit United Way of Northeastern Minnesota 2Health News:Cogdell Spencer Announces Aigner as President in the Northwest Region 2Health News:Cogdell Spencer Announces Aigner as President in the Northwest Region 3Health News:Tuba Spells Trouble for Young Musician 2Health News:Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results 2Health News:Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results 3Health News:Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results 4Health News:Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results 5Health News:Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results 6Health News:Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results 7Health News:Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results 8Health News:Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results 9Health News:Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results 10Health News:Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results 11Health News:Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results 12Health News:Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results 13Health News:Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results 14Health News:Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results 15
... the first and only one-bottle lens care ... conditions gas permeable contact lenses, but also ... the leading two-bottle GP lens care system. ... insertion by enveloping the lenses and creating ...
Menicon Z is a rigid gas lens with high oxygen permeability. As one of its specific characteristics, it can provide superior visual correction and show excellent performance against astigmatism....
... using sophisticated lathing techniques, intrinsically permeable polymers ... a center thickness of just 0.08 across ... powered Thinsite lenses maintain a 30% decrease ... unique design eliminates stress points to reduce ...
Boston Multivision design is manufactured in Boston ES material for early presbyope patients. Boston Multivision lens provides crisp, clear vision at near, intermediate, and far distances and excelle...
Medicine Products: